Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Learn why blockchain can operate without Bitcoin, focusing on architecture, governance models, and use cases beyond cryptocurrency.
28,321 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Analysts released a fresh batch of top calls on Thursday, reshaping sentiment across industrials and tech as earnings...
Analysts say the United States holds roughly $45 trillion in natural resources, a cushion that could delay debt press...
JPMorgan trimmed its price target on Advance Auto Parts to $59 from $64, citing tax stimulus as a partial offset to h...
Rate has added Scottsdale, Arizona-based loan originator Kelsey Marquardt to its Chicago-based mortgage platform, sig...
A surge of fear, uncertainty, and doubt sweeps social feeds as Ethereum faces ETF-driven volatility. This report brea...
New data shows wealth grows more from steady saving and patient investing than from big salaries. The piece outlines ...
Two $2 trillion companies are anchoring Intel’s AI roadmap with a $5 billion NVIDIA investment and a multiyear Google...
With unemployment data signaling a slower hiring cycle, investors are turning to enterprise automation. This article ...
Shoppers are pouring money into immune-boosting supplements in 2026, with colostrum products among the hottest catego...
As June trading hits mid-month, investors eye three mega-cap cloud leaders for renewed growth and long-term backlog s...
Micron Technology has delivered a stunning 770% year-to-date surge as AI-driven memory demand intensifies. The rally ...